Searle, Chinese firm strike deal to make Covid vaccine in Pakistan - Pakistan

A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan. — Reuters/File
KARACHI: A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan, an official announcement said on Thursday.
This has emerged in a letter written by M/s Searle Company Limited to the Pakistan Stock Exchange, saying it had concluded an agreement with China’s Livzon Mapharm Inc. for manufacturing novel coronavirus vaccine (V-01) in Pakistan.
“Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” the company said.

Related Keywords

China ,Pakistan ,Karachi ,Sindh ,Chinese , ,China Livzon Mapharm Inc ,Pakistan Stock Exchange ,Livzon Mapharm Inc ,Oxford University Astrazeneca ,Drug Regulatory Authority Of Pakistan ,Searle Company ,Searle Company Limited ,Livzon Mapharm ,Recombinant Novel Coronavirus Vaccine ,Recombinant Novel ,Drug Regulatory Authority ,Oxford University ,Corona Virus ,சீனா ,பாக்கிஸ்தான் ,கராச்சி ,சிந்த் ,சீன ,பாக்கிஸ்தான் ஸ்டாக் பரிமாற்றம் ,மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் ,தேடல் நிறுவனம் ,தேடல் நிறுவனம் வரையறுக்கப்பட்டவை ,மறுசீரமைப்பு நாவல் ,மருந்து ஒழுங்குமுறை அதிகாரம் ,ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் ,கொரோனா வைரஸ் ,